These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1103 related items for PubMed ID: 12792379

  • 1. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [Abstract] [Full Text] [Related]

  • 2. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
    Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
    [Abstract] [Full Text] [Related]

  • 3. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
    Leibovitz E, Piglansky L, Raiz S, Greenberg D, Hamed KA, Ledeine JM, Press J, Leiberman A, Echols RM, Pierce PF, Jacobs MR, Dagan R.
    Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364
    [Abstract] [Full Text] [Related]

  • 4. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?
    Leibovitz E, Satran R, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 Jun; 22(6):509-15. PubMed ID: 12799507
    [Abstract] [Full Text] [Related]

  • 5. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
    Guven M, Bulut Y, Sezer T, Aladag I, Eyibilen A, Etikan I.
    Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
    [Abstract] [Full Text] [Related]

  • 6. Microbiology of otitis media in Costa Rican children, 1999 through 2001.
    Arguedas A, Dagan R, Soley C, Loaiza C, Knudsen K, Porat N, Pérez A, Brilla E, Herrera ML.
    Pediatr Infect Dis J; 2003 Dec; 22(12):1063-8. PubMed ID: 14688566
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
    Arguedas A, Dagan R, Leibovitz E, Hoberman A, Pichichero M, Paris M.
    Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
    [Abstract] [Full Text] [Related]

  • 8. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media.
    Leiberman A, Leibovitz E, Piglansky L, Raiz S, Press J, Yagupsky P, Dagan R.
    Pediatr Infect Dis J; 2001 Mar; 20(3):260-4. PubMed ID: 11303827
    [Abstract] [Full Text] [Related]

  • 9. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
    Leibovitz E.
    Paediatr Drugs; 2003 Mar; 5 Suppl 1():1-12. PubMed ID: 14632101
    [Abstract] [Full Text] [Related]

  • 10. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P.
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [Abstract] [Full Text] [Related]

  • 11. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
    Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B.
    Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971
    [Abstract] [Full Text] [Related]

  • 12. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R.
    Clin Infect Dis; 2005 Jul 01; 41(1):35-41. PubMed ID: 15937760
    [Abstract] [Full Text] [Related]

  • 13. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management.
    Marchisio P, Claut L, Rognoni A, Esposito S, Passali D, Bellussi L, Drago L, Pozzi G, Mannelli S, Schito G, Principi N.
    Pediatr Infect Dis J; 2003 Mar 01; 22(3):262-8. PubMed ID: 12634589
    [Abstract] [Full Text] [Related]

  • 14. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
    Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R.
    Pediatr Infect Dis J; 2012 Feb 01; 31(2):154-8. PubMed ID: 21983212
    [Abstract] [Full Text] [Related]

  • 15. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar 01; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, McNeeley DF, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2006 Dec 01; 25(12):1102-9. PubMed ID: 17133154
    [Abstract] [Full Text] [Related]

  • 18. Seasonal distribution of otitis media pathogens among Costa Rican children.
    Guevara S, Soley C, Arguedas A, Porat N, Dagan R.
    Pediatr Infect Dis J; 2008 Jan 01; 27(1):12-6. PubMed ID: 18162931
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec 01; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK.
    Indian J Pediatr; 2005 Mar 01; 72(3):233-8. PubMed ID: 15812119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.